Immune Pharmaceuticals (IMNPQ)
OTHER OTC:IMNPQ
Holding IMNPQ?
Track your performance easily

Immune Pharmaceuticals (IMNPQ) Income Statement

0 Followers

Immune Pharmaceuticals Income Statement

Last quarter (Q ), Immune Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, Immune Pharmaceuticals's net income was $-9.67M. See Immune Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 17Dec 16Dec 15Dec 14Dec 13
Total Revenue
-$ 0.00$ 0.00$ 0.00$ 2.00K$ 19.00K
Cost of Revenue
----$ 0.00$ 0.00
Gross Profit
----$ 2.00K$ 19.00K
Operating Expense
$ 14.67M$ 12.12M$ 27.26M$ 15.72M$ 16.36M$ 9.02M
Operating Income
$ -14.67M$ -12.12M$ -27.26M$ -15.72M$ -16.36M$ -9.00M
Net Non Operating Interest Income Expense
$ 138.00K$ -3.65M$ -1.55M$ -827.00K$ -3.40M$ -305.00K
Other Income Expense
$ -3.82M$ -4.08M$ -8.70M$ -606.00K$ -3.78M$ 3.56M
Pretax Income
$ -18.36M$ -19.86M$ -37.52M$ -17.16M$ -23.55M$ -5.75M
Tax Provision
$ -1.97M$ -1.97M$ -4.86M$ 0.00$ 0.00$ 11.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -34.39M$ -24.75M$ -40.63M$ -24.12M$ -24.42M$ -6.69M
Basic EPS
$ -1.87$ -2.11$ -9.58$ -18.00$ -29.20$ -18.80
Diluted EPS
$ -1.87$ -2.11$ -9.58$ -18.00$ -29.20$ -18.80
Basic Average Shares
$ 98.84M$ 11.76M$ 4.24M$ 1.34M$ 837.13K$ 354.44K
Diluted Average Shares
$ 98.84M$ 11.76M$ 4.24M$ 1.34M$ 837.13K$ 354.44K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 14.67M$ 12.12M$ 27.26M$ 15.72M$ 16.36M$ 9.02M
Net Income From Continuing And Discontinued Operation
$ -16.38M$ -17.89M$ -32.66M$ -17.16M$ -23.55M$ -5.76M
Normalized Income
$ -15.81M$ -15.82M$ -25.13M$ -16.55M$ -19.77M$ -8.07M
Interest Expense
$ -138.00K$ 3.65M$ 1.55M$ 827.00K$ 3.40M$ 305.00K
EBIT
$ -18.49M$ -16.21M$ -35.96M$ -16.33M$ -20.15M$ -5.44M
EBITDA
$ -17.59M$ -15.55M$ -35.57M$ -16.00M$ -19.82M$ -5.14M
Currency in USD

Immune Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis